Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2011 Publisher: Orpha-Devel Handels und Vertriebs GmbH, Wintergasse 85/1B, A-3002, Purkersdorf, Austria
NALPAIN 10 mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. The solution is clear and colourless. pH = 3.0-4.2, osmolarity = 0.3 Osmol/kg |
1 ml solution for injection contains 10 mg nalbuphine hydrochloride.
1 ampoule of 2 ml contains 20 mg nalbuphine hydrochloride.
Excipient: 1.6 mg sodium in a 2 ml ampoule.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nalbuphine |
Nalbuphine is an opioid with kappa-agonistic and mu-antagonistic properties. Beside the essential agonistic (analgesic) effect nalbuphine has antagonistic effects of about a fourth of nalorfine and ten times of pentazocine. |
| List of Excipients |
|---|
|
Citric acid, anhydrous |
Colourless glass, Type I.
Ampoules of 2 ml, in packages of 10 ampoules.
Orpha-Devel Handels und Vertriebs GmbH, Wintergasse 85/1B, A-3002, Purkersdorf, Austria
PL 30414/0003
21/02/2008 / 20/01/2011
| Drug | Countries | |
|---|---|---|
| NALPAIN | Estonia, France, Poland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
